Taken together Figs. 3A&B show that in vivo modulation of AIRE expression in tumours can be used to enhance adoptive T cell therapies with a close dependency upon whether the T cell target antigen is AIRE regulated or not. The gene discussed is AIRE; the disease is neoplasm.